These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 27746144)

  • 1. An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.
    Villa GR; Hulce JJ; Zanca C; Bi J; Ikegami S; Cahill GL; Gu Y; Lum KM; Masui K; Yang H; Rong X; Hong C; Turner KM; Liu F; Hon GC; Jenkins D; Martini M; Armando AM; Quehenberger O; Cloughesy TF; Furnari FB; Cavenee WK; Tontonoz P; Gahman TC; Shiau AK; Cravatt BF; Mischel PS
    Cancer Cell; 2016 Nov; 30(5):683-693. PubMed ID: 27746144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
    Guo D; Reinitz F; Youssef M; Hong C; Nathanson D; Akhavan D; Kuga D; Amzajerdi AN; Soto H; Zhu S; Babic I; Tanaka K; Dang J; Iwanami A; Gini B; Dejesus J; Lisiero DD; Huang TT; Prins RM; Wen PY; Robins HI; Prados MD; Deangelis LM; Mellinghoff IK; Mehta MP; James CD; Chakravarti A; Cloughesy TF; Tontonoz P; Mischel PS
    Cancer Discov; 2011 Oct; 1(5):442-56. PubMed ID: 22059152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma.
    Liu F; Mischel PS
    Wiley Interdiscip Rev Syst Biol Med; 2018 Jan; 10(1):. PubMed ID: 28892308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
    Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
    Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1.
    Patel D; Ahmad F; Kambach DM; Sun Q; Halim AS; Kramp T; Camphausen KA; Stommel JM
    Sci Rep; 2019 Oct; 9(1):15458. PubMed ID: 31664073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl-xL inhibition.
    Nguyen TTT; Ishida CT; Shang E; Shu C; Torrini C; Zhang Y; Bianchetti E; Sanchez-Quintero MJ; Kleiner G; Quinzii CM; Westhoff MA; Karpel-Massler G; Canoll P; Siegelin MD
    EMBO Mol Med; 2019 Oct; 11(10):e10769. PubMed ID: 31468706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
    Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
    Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new LXRβ agonists as glioblastoma inhibitors.
    Chen H; Chen Z; Zhang Z; Li Y; Zhang S; Jiang F; Wei J; Ding P; Zhou H; Gu Q; Xu J
    Eur J Med Chem; 2020 May; 194():112240. PubMed ID: 32248003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Deoxyschweinfurthin B Lowers Cholesterol Levels by Decreasing Synthesis and Increasing Export in Cultured Cancer Cell Lines.
    Kuder CH; Weivoda MM; Zhang Y; Zhu J; Neighbors JD; Wiemer DF; Hohl RJ
    Lipids; 2015 Dec; 50(12):1195-207. PubMed ID: 26494560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers.
    Poirot M; Silvente-Poirot S
    Biochem Pharmacol; 2018 Jul; 153():75-81. PubMed ID: 29409832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientists target cholesterol to treat brain tumors.
    Printz C
    Cancer; 2012 Feb; 118(4):869. PubMed ID: 22307883
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential Role of Liver X Receptor (LXR)
    Hansmann E; Mennillo E; Yoda E; Verreault M; Barbier O; Chen S; Tukey RH
    Drug Metab Dispos; 2020 Apr; 48(4):255-263. PubMed ID: 31980500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
    Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
    Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.
    Ceroi A; Masson D; Roggy A; Roumier C; Chagué C; Gauthier T; Philippe L; Lamarthée B; Angelot-Delettre F; Bonnefoy F; Perruche S; Biichle S; Preudhomme C; Macintyre E; Lagrost L; Garnache-Ottou F; Saas P
    Blood; 2016 Dec; 128(23):2694-2707. PubMed ID: 27702801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression.
    Kaneko T; Kanno C; Ichikawa-Tomikawa N; Kashiwagi K; Yaginuma N; Ohkoshi C; Tanaka M; Sugino T; Imura T; Hasegawa H; Chiba H
    Oncotarget; 2015 Oct; 6(32):33345-57. PubMed ID: 26452260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Distribution and Efficacy of the Brain Penetrant PI3K Inhibitor GDC-0084 in Orthotopic Mouse Models of Human Glioblastoma.
    Salphati L; Alicke B; Heffron TP; Shahidi-Latham S; Nishimura M; Cao T; Carano RA; Cheong J; Greve J; Koeppen H; Lau S; Lee LB; Nannini-Pepe M; Pang J; Plise EG; Quiason C; Rangell L; Zhang X; Gould SE; Phillips HS; Olivero AG
    Drug Metab Dispos; 2016 Dec; 44(12):1881-1889. PubMed ID: 27638506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
    Miekus K; Kijowski J; Sekuła M; Majka M
    Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.